For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Thallion Pharmaceuticals Inc.

USPTO Granted Patents = 14

EPO Patents = 1

Forward Citations = 28

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Emmanuel Zazopoulos (8 out of 14 patents)

Chris M Farnet (8 out of 17 patents)

James B McAlpine (7 out of 10 patents)

4. Arjun H Banskota (4 out of 4 patents)

5. Alfredo Staffa (3 out of 8 patents)

6. Mustapha Aouidate (3 out of 3 patents)

7. Brian O Bachmann (2 out of 7 patents)

8. François Berger (2 out of 10 patents)

9. Mahmood Piraee (2 out of 4 patents)

10. Faustinus Yeboah (2 out of 2 patents)

11. Henriette Gourdeau (2 out of 5 patents)

12. Maxime Ranger (2 out of 7 patents)

13. Pierre Falardeau (1 out of 3 patents)

14. Bryan Simard (1 out of 1 patent)

15. Ashraf Ibrahim (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 8361759 - Process for producing farnesylated dibenzodiazepinone by fermentation (2013-01-29),

2. 8076287 - Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals (2011-12-13),

3. 7763604 - Methods for administration of a farnesyl dibenzodiazepinone (2010-07-27),

4. 7655646 - Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals (2010-02-02),

5. 7635765 - Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin (2009-12-22),

6. 7521222 - Farnesyl dibenzodiazepinone and processes for its production (2009-04-21),

7. 7462705 - Nucleic acids encoding an enediyne polyketide synthase complex (2008-12-09),

8. 7416868 - Polyene polyketides, processes for their production and their use as a pharmaceutical (2008-08-26),

9. 7384935 - Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals (2008-06-10),

10. 7375088 - Polyene polyketides, processes for their production and their use as a pharmaceutical (2008-05-20),

11. 7358241 - Compositions and methods comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions (2008-04-15),

12. 7312339 - Polyene oxazoles and processes for their preparation (2007-12-25),

13. 7304054 - Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals (2007-12-04),

14. 7257562 - High throughput method for discovery of gene clusters (2007-08-14),

Thallion Pharmaceuticals Inc. is a biotechnology company focused on the discovery and development of innovative pharmaceutical products. With a strong emphasis on research and development, Thallion strives to create novel therapies for unmet medical needs. Through their cutting-edge platforms and strategic partnerships, Thallion aims to improve patient outcomes and enhance the quality of life for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

14 Patents

#59 in Montreal

#1,015 in Canada

#40,882 in the World

Montreal, Canada

Thallion Pharmaceuticals Inc.

Forward Citations = 28

18 inventors:

Emmanuel Zazopoulos (8 out of 14 patents)

Chris M Farnet (8 out of 17 patents)

James B McAlpine (7 out of 10 patents)

4. Arjun H Banskota (4 out of 4 patents)

5. Alfredo Staffa (3 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…